The Centers for Medicare and Medicaid Services (CMS) has revealed the prices for the second batch of 15 drugs going through ...

Anti-APRIL antibody Voyxact (sibeprenlimab) has been approved by the US regulator to reduce proteinuria in adults with ...

Sanofi is being probed for 'money laundering of tax fraud', 'money laundering of tax fraud by an organised or aggravated ...

Veeva’s latest report, The State of Data, Analytics, and AI in Commercial Biopharma, revealed a critical industry paradox: ...

Kelonia Therapeutics only started human testing of its in vivo CAR-T therapy for multiple myeloma in August, but already has ...

Novo Nordisk is filing its supplemental new drug application (sNDA) for Wegovy 7.2 mg on the back of the phase 3b STEP UP ...

Digital health and digital therapeutics have been around for a long time now. But when will we really start to realise the ...

The Autumn Budget, with its £26 billion tax rise by 2029-30, will “drive an exodus of wealth from Britain,” warned Nigel ...

Prenuvo CEO Andrew Lacy sat down with pharmaphorum after their Frontiers Health keynote to discuss: ...

Novo Nordisk said it will now move ahead with a phase 3 programme for both versions of the drug in adults with type 2 ...

Novo Nordisk has jumped the gun on US price reductions for its blockbuster diabetes and weight-loss drug semaglutide, cutting the monthly price to $349, earlier than expected, for people willing to ...

The new intrathecal formulation means the one-shot gene therapy is now available to all SMA patients, regardless of their age ...